4-氨基-2-氯嘧啶-5-甲酰胺 | 98027-38-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 4-氨基-2-氯嘧啶-5-甲酰胺
• 英文名称: 4-amino-2-chloropyrimidine-5-carboxamide
• CAS: 98027-38-4
• 化学式: C₅H₅ClN₄O
• mdl: MFCD11500804
• 分子量: 172.574
• InChiKey: SEQWNBBMRHGRPX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  94.9
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-氨基-2-氯嘧啶-5-甲酰胺 、 环戊硫醇 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 4-Amino-2-cyclopentylsulfanylpyrimidine-5-carboxamide
  参考文献：
  名称：

  Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: Aminoalkoxypyrimidine carboxamides

  摘要：

  A series of 2,6-disubstituted aminoalkoxypyrimidine carboxamides (AAPCs) with potent inhibition of bacterial NAD(+)-dependent DNA ligase was discovered through the use of structure-guided design. Two subsites in the NAD(+)-binding pocket were explored to modulate enzyme inhibitory potency: a hydrophobic selectivity region was explored through a series of 2-alkoxy substituents while the sugar (ribose) binding region of NAD(+) was explored via 6-alkoxy substituents. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.04.037

文献信息

• SYNTHESIS OF CERDULATINIB
  申请人：Portola Pharmaceuticals, Inc.

  公开号：US20210147392A1

  公开（公告）日：2021-05-20

  The present disclosure provides processes for the preparation of cerdulatinib, which is of formula I: or a salt thereof. The disclosure also provides intermediates and processes for the preparation of the intermediates useful in the preparation of cerdulatinib or a salt thereof.

  本公开提供了制备cerdulatinib的过程，其化学式为I：或其盐。本公开还提供了中间体和制备中间体的过程，这些中间体在制备cerdulatinib或其盐时有用。
• Synthesis of cerdulatinib
  申请人：Portola Pharmaceuticals, Inc.

  公开号：US10851087B2

  公开（公告）日：2020-12-01

  The present disclosure provides processes for the preparation of cerdulatinib, which is of formula I: or a salt thereof. The disclosure also provides intermediates and processes for the preparation of the intermediates useful in the preparation of cerdulatinib or a salt thereof.

  本公开提供了制备式 I 的 cerdulatinib 的工艺： 或其盐的工艺。本公开还提供了用于制备cerdulatinib或其盐的中间体及其制备工艺。
• PROTEIN KINASE C INHIBITORS AND USES THEREOF
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：EP2833889B1

  公开（公告）日：2017-11-01
• [EN] PROTEIN KINASE C INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE PROTÉINE KINASE C ET LEURS UTILISATIONS
  申请人：RIGEL PHARMACEUTICALS INC

  公开号：WO2014151900A1

  公开（公告）日：2014-09-25

  This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
• Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: Aminoalkoxypyrimidine carboxamides
  作者：Wenxin Gu、Tiansheng Wang、Francois Maltais、Brian Ledford、Joseph Kennedy、Yunyi Wei、Christian H. Gross、Jonathan Parsons、Leonard Duncan、S.J. Ryan Arends、Cameron Moody、Emanuele Perola、Jeremy Green、Paul S. Charifson

  DOI：10.1016/j.bmcl.2012.04.037

  日期：2012.6

  A series of 2,6-disubstituted aminoalkoxypyrimidine carboxamides (AAPCs) with potent inhibition of bacterial NAD(+)-dependent DNA ligase was discovered through the use of structure-guided design. Two subsites in the NAD(+)-binding pocket were explored to modulate enzyme inhibitory potency: a hydrophobic selectivity region was explored through a series of 2-alkoxy substituents while the sugar (ribose) binding region of NAD(+) was explored via 6-alkoxy substituents. (C) 2012 Elsevier Ltd. All rights reserved.